Literature DB >> 20668839

Effects of ropinirole on action potential characteristics and the underlying ion currents in canine ventricular myocytes.

József Simkó1, Norbert Szentandrássy, Gábor Harmati, László Bárándi, Balázs Horváth, János Magyar, Tamás Bányász, István Lorincz, Péter P Nánási.   

Abstract

In spite of its widespread clinical application, there is little information on the cellular cardiac effects of the dopamine receptor agonist ropinirole. In the present study, therefore, the concentration-dependent effects of ropinirole on action potential morphology and the underlying ion currents were studied in enzymatically dispersed canine ventricular cardiomyocytes using standard microelectrode, conventional whole-cell patch clamp, and action potential voltage clamp techniques. At concentrations > or = 1 microM, ropinirole increased action potential duration (APD(90)) and suppressed the rapid delayed rectifier K(+) current (I (Kr)) with an IC(50) value of 2.7 +/- 0.25 microM and Hill coefficient of 0.92 +/- 0.09. The block increased with increasing depolarizations to more positive voltages, but paradoxically, the activation of I (Kr) was accelerated by 3 muM ropinirole (time constant decreased from 34 +/- 4 to 14 +/- 1 ms). No significant changes in the fast and slow deactivation time constants were observed with ropinirole. At higher concentrations, ropinirole decreased the amplitude of early repolarization (at concentrations > or = 10 microM), reduced the maximum rate of depolarization and caused depression of the plateau (at concentrations > or = 30 microM), and shortened APD measured at 50% repolarization (at 300 microM) indicating a concentration-dependent inhibition of I (to), I (Na), and I (Ca). Suppression of I (Kr), I (to), and I (Ca) has been confirmed under conventional patch clamp and action potential voltage clamp conditions. I (Ks) and I (K1) were not influenced significantly by ropinirole at concentrations less than 300 microM. All these effects of ropinirole were fully reversible upon washout. The results indicate that ropinirole treatment may carry proarrhythmic risk for patients with inherited or acquired long QT syndrome due to inhibition of I (Kr)-especially in cases of accidental overdose or intoxication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668839     DOI: 10.1007/s00210-010-0538-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium.

Authors:  Norbert Szentadrassy; Tamas Banyasz; Tamas Biro; Gergely Szabo; Balazs I Toth; Janos Magyar; Jozsef Lazar; Andras Varro; Laszlo Kovacs; Peter P Nanasi
Journal:  Cardiovasc Res       Date:  2005-03-01       Impact factor: 10.787

2.  Asymmetrical distribution of ion channels in canine and human left-ventricular wall: epicardium versus midmyocardium.

Authors:  Gergely Szabó; Norbert Szentandrássy; Tamás Bíró; Balázs I Tóth; Gabriella Czifra; János Magyar; Tamás Bányász; András Varró; László Kovács; Péter P Nánási
Journal:  Pflugers Arch       Date:  2005-06-11       Impact factor: 3.657

3.  Action potential clamp fingerprints of K+ currents in canine cardiomyocytes: their role in ventricular repolarization.

Authors:  T Bányász; J Magyar; N Szentandrássy; B Horváth; P Birinyi; J Szentmiklósi; P P Nánási
Journal:  Acta Physiol (Oxf)       Date:  2007-03-30       Impact factor: 6.311

4.  The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.

Authors:  A E Schrag; D J Brooks; E Brunt; D Fuell; A Korczyn; W Poewe; N P Quinn; O Rascol; F Stocchi
Journal:  Clin Neuropharmacol       Date:  1998 May-Jun       Impact factor: 1.592

5.  Pharmacokinetics of dopamine-2 agonists in rats and dogs.

Authors:  J E Swagzdis; R W Wittendorf; R M DeMarinis; B A Mico
Journal:  J Pharm Sci       Date:  1986-10       Impact factor: 3.534

6.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

7.  Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.

Authors:  Richard B Dewey; Sharon C Reimold; Padraig E O'Suilleabhain
Journal:  Arch Neurol       Date:  2007-03

Review 8.  Clinical pharmacokinetics of ropinirole.

Authors:  C M Kaye; B Nicholls
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

9.  Ropinirole-induced symptomatic sinus node dysfunction.

Authors:  Catherine Szymanski; Serge Boey; Jean S Hermida
Journal:  Pacing Clin Electrophysiol       Date:  2008-08       Impact factor: 1.976

Review 10.  Serotonergic drugs and valvular heart disease.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Expert Opin Drug Saf       Date:  2009-05       Impact factor: 4.250

View more
  4 in total

1.  Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.

Authors:  Ferenc Ruzsnavszky; Bence Hegyi; Kornél Kistamás; Krisztina Váczi; Balázs Horváth; Norbert Szentandrássy; Tamás Bányász; Péter P Nánási; János Magyar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-25       Impact factor: 3.000

2.  Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.

Authors:  Balázs Horváth; Norbert Szentandrássy; Roland Veress; János Almássy; János Magyar; Tamás Bányász; Attila Tóth; Zoltán Papp; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-22       Impact factor: 3.000

3.  Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.

Authors:  László Szabó; Norbert Szentandrássy; Kornél Kistamás; Bence Hegyi; Ferenc Ruzsnavszky; Krisztina Váczi; Balázs Horváth; János Magyar; Tamás Bányász; Balázs Pál; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-19       Impact factor: 3.000

4.  Use of whole exome sequencing for the identification of Ito-based arrhythmia mechanism and therapy.

Authors:  Amy C Sturm; Crystal F Kline; Patric Glynn; Benjamin L Johnson; Jerry Curran; Ahmet Kilic; Robert S D Higgins; Philip F Binkley; Paul M L Janssen; Raul Weiss; Subha V Raman; Steven J Fowler; Silvia G Priori; Thomas J Hund; Cynthia A Carnes; Peter J Mohler
Journal:  J Am Heart Assoc       Date:  2015-05-26       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.